Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Rene Olivier Casasnovas"'
Autor:
Amira Marouf, Sammara Chaubard, Jean Marie Michot, Julien Rossignol, Camille Golfier, Olivier Allangba, Laure Philippe, Benoit Tessoulin, Adrien Chauchet, Bénédicte Deau, Lucie Oberic, Jacques Vargaftig, Aline Moignet, Aline Clavert, Rémy Duléry, Gabriel Brisou, Stéphanie Tardy, Virginie Fataccioli, Roch Houot, Rene Olivier Casasnovas, Catherine Thieblemont, Herve Ghesquieres, Sylvain Carras, Steven Le Gouill, Guillaume Cartron, Aurélien Marabelle, Olivier Tournilhac, Gandhi Laurent Damaj, Philippe Gaulard, Laurence De Leval, Francois Lemonnier, Emmanuel Bachy, Olivier Hermine, Lucile Couronné, Arnaud Jaccard
Publikováno v:
HemaSphere, Vol 7, p e41118bf (2023)
Externí odkaz:
https://doaj.org/article/e33362dfb2354a62a968dabc1e6fcb1d
Autor:
Roch Houot, Emmanuel Bachy, Guillaume Cartron, Francois-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Rene Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques Olivier Bay, Francisco Llamas, Cedric Menard, Karin Tarte, Marie-Helene Delfau-Larue, Emmanuel Itti, Clément Bailly, Yassine Al Tabaa, Camille Laurent, Francois Lemonnier
Publikováno v:
HemaSphere, Vol 7, p e56791ba (2023)
Externí odkaz:
https://doaj.org/article/d49be4bdc21f462da89ea5f57b563b5d
Autor:
Steven Le Gouill, Franck Morschhauser, David Chiron, Kamal Bouabdallah, Guillaume Cartron, Rene Olivier Casasnovas, Caroline Milin, Charles Herbaux, Emmanuelle Tchernonog, Cedric Rossi, Simon Rule, Thomas Gastinne, Mary Callanan, Benoit Tessoulin
Publikováno v:
HemaSphere, Vol 7, p e6048802 (2023)
Externí odkaz:
https://doaj.org/article/76c6128b222f4566b551a30fd6cdca59
Autor:
Clementine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Kamal Bouabdallah, Gandhi Laurent Damaj, Thomas Gastinne, Vincent Ribrag, Rene Olivier Casasnovas, Corinne Haioun, Roch Houot, Fabrice Jardin, Eric Van Den Neste, Morgane Cheminant, Franck Morschhauser, Mary Callanan, Herve Ghesquieres, Remy Gressin, Olivier Hermine, Steven Le Gouill
Publikováno v:
HemaSphere, Vol 7, p e06197a0 (2023)
Externí odkaz:
https://doaj.org/article/89882d6e64974915b9528d628dd60242
Autor:
Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Ibrahim Yakoub-Agha, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Rene Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stephanie Guidez, Michael Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Roch Houot
Publikováno v:
HemaSphere, Vol 7, p e22232d3 (2023)
Externí odkaz:
https://doaj.org/article/fca5e4d3d42e49ed8f7a3ba701f98e5f
Autor:
Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, Paul Deschamps, Michel Meignan, Patricia Franchi, David Sibon, Clara Antoine, Thomas Gastinne, Cecile Borel, Mohammad Hammoud, Guillaume Sicard, Romane Gille, Doriane Cavalieri, Aspasia Stamatoullas, Lauriane Filliatre-Clement, Julien Lazarovici, Adrien Chauchet, Luc-Matthieu Fornecker, Sandy Amorin, Mathieu Rocquet, Nicole Raus, Barbara Burroni, Marie Therese Rubio, Didier Bouscary, Philippe Quittet, Rene Olivier Casasnovas, Pauline Brice, Herve Ghesquieres, Jérôme Tamburini, Benedicte Deau
Publikováno v:
Haematologica, Vol 107, Iss 7 (2021)
Externí odkaz:
https://doaj.org/article/6b708453982648f4a527b943287d469e
Autor:
Asma Beldi‐Ferchiou, Jean‐Philippe Jais, Hervé Ghesquieres, Rene Olivier Casasnovas, Hervé Tilly, Christophe Fruchart, Franck Morschhauser, Corinne Haioun, Julien Lazarovici, Aurore Perrot, Emmanuelle Nicolas‐Virelizier, Gilles Salles, Nathalie Godard, Imen Zamali, Jean‐Marc Schiano De Colella, Alexis Claudel, Bernadette Corront, Lucie Oberic, Josette Briere, Philippe Gaulard, Catherine Thieblemont, Marie‐Hélène Delfau‐Larue
Publikováno v:
British Journal of Haematology. 201:256-266
Autor:
Franck, Morschhauser, Loretta, Nastoupil, Pierre, Feugier, Jean-Marc, Schiano de Colella, Hervé, Tilly, Maria Lia, Palomba, Emmanuel, Bachy, Christophe, Fruchart, Edward N, Libby, Rene-Olivier, Casasnovas, Ian W, Flinn, Corinne, Haioun, Hervé, Maisonneuve, Loic, Ysebaert, Nancy L, Bartlett, Kamal, Bouabdallah, Pauline, Brice, Vincent, Ribrag, Steven, Le Gouill, Nicolas, Daguindau, Stéphanie, Guidez, Gian Matteo, Pica, Alejandro Martín, García-Sancho, Armondo, López-Guillermo, Jean-François, Larouche, Kiyoshi, Ando, Maria, Gomes da Silva, Marc, André, Wu, Kalung, Laurie H, Sehn, Koji, Izutsu, Guillaume, Cartron, Argyrios, Gkasiamis, Russell, Crowe, Luc, Xerri, Nathan H, Fowler, Gilles, Salles
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(28)
Autor:
Michael Schuster, Josée Zijlstra, Rene-Olivier Casasnovas, Joost S.P Vermaat, Nagesh Kalakonda, Andre Goy, Sylvain Choquet, Eric Van Den Neste, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, George Follows, Miklos Egyed, Fritz Offner, Theodoros Vassilakopoulos, Priyanka Samal, Matthew Ku, Xiwen Ma, Kelly Corona, Kamal Chamoun, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Miguel Canales, Marie Maerevoet
Publikováno v:
Clinical Lymphoma, Myeloma and Leukemia, 22(7), 483-494. Cancer Media Group
Clinical Lymphoma, Myeloma and Leukemia, 22(7), 483-494. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Schuster, M, Zijlstra, J, Casasnovas, R-O, Vermaat, J S P, Kalakonda, N, Goy, A, Choquet, S, Neste, E V D, Hill, B, Thieblemont, C, Cavallo, F, de la Cruz, F, Kuruvilla, J, Hamad, N, Jaeger, U, Caimi, P, Gurion, R, Warzocha, K, Bakhshi, S, Sancho, J-M, Follows, G, Egyed, M, Offner, F, Vassilakopoulos, T, Samal, P, Ku, M, Ma, X, Corona, K, Chamoun, K, Shah, J, Shacham, S, Kauffman, M G, Canales, M & Maerevoet, M 2022, ' Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL) : A Post-hoc Analysis of the SADAL Study ', Clinical Lymphoma, Myeloma and Leukemia, vol. 22, no. 7, pp. 483-494 . https://doi.org/10.1016/j.clml.2021.12.016
Clinical lymphoma, myeloma & leukemia, Vol. 22, no.7, p. 483-494 (2022)
Clinical Lymphoma, Myeloma and Leukemia, 22(7), 483-494. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Schuster, M, Zijlstra, J, Casasnovas, R-O, Vermaat, J S P, Kalakonda, N, Goy, A, Choquet, S, Neste, E V D, Hill, B, Thieblemont, C, Cavallo, F, de la Cruz, F, Kuruvilla, J, Hamad, N, Jaeger, U, Caimi, P, Gurion, R, Warzocha, K, Bakhshi, S, Sancho, J-M, Follows, G, Egyed, M, Offner, F, Vassilakopoulos, T, Samal, P, Ku, M, Ma, X, Corona, K, Chamoun, K, Shah, J, Shacham, S, Kauffman, M G, Canales, M & Maerevoet, M 2022, ' Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL) : A Post-hoc Analysis of the SADAL Study ', Clinical Lymphoma, Myeloma and Leukemia, vol. 22, no. 7, pp. 483-494 . https://doi.org/10.1016/j.clml.2021.12.016
Clinical lymphoma, myeloma & leukemia, Vol. 22, no.7, p. 483-494 (2022)
Patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have a poor prognosis and a median overall survival of less than 6 months. Outcomes and responses were evaluated in 134 patients with DLBCL administered selinexor. Our findin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c552e91c038aad7ab0c4e8f1a6e66e16
https://research.vumc.nl/en/publications/38c12e5e-a745-4e46-a370-f396ce1e4eb3
https://research.vumc.nl/en/publications/38c12e5e-a745-4e46-a370-f396ce1e4eb3
Autor:
Agnes Nagy, Rene-Olivier Casasnovas, Sameer Bakhshi, Sharon Shacham, Juan-Manuel Sancho, Ronit Gurion, Josée M. Zijlstra, Jatin P. Shah, Miklos Egyed, Brian T. Hill, Krzysztof Warzocha, Gabriel Tremblay, Michael W. Schuster, Fritz Offner, Reda Bouabdallah, Dimitrios Tomaras, Paolo Caimi, Andre Goy, Priyanka Samal, Catherine Thieblemont, Joost S.P. Vermaat, Matthew Ku, Ulrich Jäger, John Kuruvilla, Nagesh Kalakonda, George A Follows, Eric Van Den Neste, Miguel Ángel Canales Albendea, Michael Kauffman, Nada Hamad, Fatima De la Cruz, Patrick Daniele, Marie Maerevoet, Theodoros Vasilakopoulos, Federica Cavallo, Sylvain Choquet
Publikováno v:
Future Oncology
Future Oncology, Future Medicine, 2021, 17 (11), pp.1295-1310. ⟨10.2217/fon-2020-0946⟩
Future Oncology, 17(11), 1295-1310. FUTURE MEDICINE LTD
FUTURE ONCOLOGY
Future oncology, Vol. 17, no.11, p. 1295-1310 (2021)
Future Oncology, Future Medicine, 2021, 17 (11), pp.1295-1310. ⟨10.2217/fon-2020-0946⟩
Future Oncology, 17(11), 1295-1310. FUTURE MEDICINE LTD
FUTURE ONCOLOGY
Future oncology, Vol. 17, no.11, p. 1295-1310 (2021)
Aim: Evaluate health-related quality of life (HRQoL) and health utility impact of single-agent selinexor in heavily pretreated patients with relapsed/refractory diffuse large B-cell lymphoma. Patients & methods: Functional Assessment of Cancer Therap